Acadia Pharmaceuticals Inc (ACAD)
Net Income Growth
18.13%
Quarterly · Period ending:
ACAD Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported18.13%period ending
Latest reported18.13%period ending
ACAD Quarterly Net Income YoY % (-90.04% → 18.13%)
Year-over-year change
High-resolution chart · PNG
ACAD net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| 18.128% | |
| -80.8448% | |
| 90.3188% | |
| 119.0722% | |
| -20.1354% | |
| 14.6904% | |
| 213.8677% | |
| 150.2716% | |
| 2,897.2172% | |
| 138.4812% | |
| 209.7591% | |
| -139.7675% | |
| 103.2754% | |
| 61.9472% | |
| 3.1768% | |
| -88.0266% | |
| 22.475% | |
| -70.1421% | |
| 35.4494% | |
| 82.9235% | |
| -4.1053% | |
| 24.5106% | |
| -25.8768% | |
| -101.6771% | |
| 23.2977% | |
| -3.1874% | |
| 19.0191% | |
| 32.4439% | |
| 13.1587% | |
| -57.1092% | |
| 4.9063% | |
| 4.7664% | |
| 6.1906% | |
| 38.1897% | |
| 12.4848% | |
| 8.8881% | |
| 5.4415% | |
| -76.5263% | |
| -71.8854% | |
| -84.0667% | |
| -81.1214% | |
| -23.2495% | |
| -61.4045% | |
| -56.9676% | |
| -83.1961% | |
| -126.4696% | |
| -135.422% | |
| -131.7532% | |
| -136.703% | |
| -191.1645% | |
| -76.931% | |
| -345.254% | |
| -67.577% | |
| 1.5278% | |
| -28.4906% | |
| 52.6793% | |
| 17.3429% | |
| -6.6004% | |
| -118.1874% | |
| -20.0852% | |
| -52.8918% | |
| -6.3058% | |
| 435.3781% | |
| 51.5697% | |
| 66.3105% | |
| 63.4224% | |
| 37.7713% | |
| 44.1014% | |
| 30.3986% | |
| 8.4188% | |
| 18.0527% | |
| 2.6862% | |
| -70.0642% | |
| -30.4763% | |
| -36.8594% | |
| -42.4576% | |
| 9.3874% | |
| -32.608% | |
| -22.0241% | |
| 8.4763% | |
| -96.5744% | |
| -69.3802% | |
| -39.1026% | |
| -98.0224% | |
| -2.555% | |
| 13.7629% | |
| -108.1887% | |
| -76.3904% | |
| -97.7592% | |
| -90.0422% |